Research | OneLook Acronym Finder |
Serial Number | 77531881 |
Registration Number | 3927271 |
Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
Attorney Name | WILLIAM SQUIRE |
Attorney Docket Number | 550730-192 |
Law Office Assigned | L10 |
Employee Name | MAYES, LAURIE ANN |
2003-12-19 | Date of First Use |
2008-07-25 | Application Filed |
2010-12-21 | Published for Opposition |
2011-03-08 | Trademark Registered |
2017-04-26 | Location: TMEG LAW OFFICE 101 |
2017-04-26 | Status: Live/Registered |
2018-07-08 | Transaction Date |
Owner: | PharmAthene, Inc. |
Address | One Park Place, Suite 450 Annapolis DE 07068 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
020302 | Silhouettes of women; Women depicted as shadows or silhouettes of women |
020322 | Busts of women in profile; Heads of women in profile; Portraiture of women in profile; Women |
190901 | Bottles, jars or flasks of conical or triangular shape; Flasks with conical or triangular shape; Jars with conical or triangular shape; Jars with conical or triangular shape |
240102 | Shields or crests with figurative elements contained therein or superimposed thereon |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
B00001 | In the statement, line 4 through 21 should be deleted, and "Pharmaceutical preparations for use in biodefense, namely, antibody based pharmaceutical products, monoclonal antibodies, vaccines, pharmaceutical preparations for treatment and prevention of Alzheimer's disease, pharmaceutical preparations for treatment and prevention of poisoning, pharmaceutical preparations for treatment and prevention of neurological disease, pharmaceutical preparations for treatment and prevention of infectious disease, recombinant based therapeutics, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for treatment and prevention of anthrax infection, pharmaceutical preparations for treatment and prevention of toxicity caused by cholinesterase inhibiting compounds in class 5" should be inserted. |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2008-07-29 | 1 NWAP I:Incoming Correspondence |
NOTICE OF DESIGN SEARCH CODE MAILED | 2008-07-30 | 2 MDSM O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2008-10-29 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2008-11-03 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2008-11-03 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2008-11-03 | 6 GNRN O:Outgoing Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2009-05-01 | 7 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2009-05-01 | 8 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2009-05-01 | 9 GNEN O:Outgoing Correspondence |
ASSIGNED TO LIE | 2009-05-01 | 10 ALIE A:Allowance for Publication |
EXAMINER'S AMENDMENT ENTERED | 2009-05-03 | 11 XAEC I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2009-05-06 | 12 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2009-05-06 | 13 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2009-05-06 | 14 GNS3 O:Outgoing Correspondence |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2009-11-06 | 15 RCSC S: |
NON-FINAL ACTION WRITTEN | 2010-05-08 | 16 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2010-05-08 | 17 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2010-05-08 | 18 GNRN O:Outgoing Correspondence |
PAPER RECEIVED | 2010-10-14 | 19 MAIL I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2010-10-22 | 20 CHAN I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2010-11-08 | 21 TROA I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2010-11-08 | 22 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2010-11-08 | 23 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2010-11-09 | 24 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2010-11-10 | 25 CNSA O:Outgoing Correspondence |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2010-11-17 | 26 PREV O:Outgoing Correspondence |
PUBLISHED FOR OPPOSITION | 2010-12-21 | 27 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2010-12-21 | 28 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2011-03-08 | 29 R.PR A:Allowance for Publication |
TEAS SECTION 7 REQUEST RECEIVED | 2011-05-27 | 30 ES7R I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2011-06-04 | 31 APRE A:Allowance for Publication |
CERTIFICATE OF CORRECTION ISSUED | 2011-06-04 | 32 COC. O:Outgoing Correspondence |
TEAS SECTION 8 & 15 RECEIVED | 2017-03-07 | 33 E815 I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2017-04-26 | 34 APRE A:Allowance for Publication |
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2017-04-26 | 35 C15A O:Outgoing Correspondence |
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2017-04-26 | 36 NA85 E:E-Mail |
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2020-03-08 | 37 REM2 E:E-Mail |
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2021-11-12 | 38 CAEX O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.